Skip to main content
Erschienen in: Cancer Causes & Control 10/2014

01.10.2014 | Commentary

RETRACTED ARTICLE: The ‘obesity paradox’ and survival after colorectal cancer: true or false?

verfasst von: Andrew G. Renehan

Erschienen in: Cancer Causes & Control | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Body mass index (BMI), as an approximation of general adiposity, is an established risk factor for incidence of several adult cancer types, including colorectal cancer (CRC). There is a common perception that these relationships extrapolate directly as adverse prognostic factors after diagnosis, but evidence for this is lacking. The paper from Sclesinger et al. in this issue of the journal adds a new dimension to this debate focusing on relationships of post-diagnosis BMI (as a marker of the steady-state weight among survivors) and survival, and provides evidence on a decreased mortality risk among overweight (post-diagnosis BMI 25.0–29.9 kg/m2) compared with normal weight (post-diagnosis BMI 18.5–24.9 kg/m2) CRC survivors—an example of an ‘obesity paradox.’ The observation of the ‘obesity paradox’ is well documented in the methodology literature, but perhaps, less familiar to the cancer readership. Three broad classes of explanation are posited: (1) the associations are true and plausible; (2) the associations are false and reflect methodological issues; or (3) the observations represent a specific form of selection bias, known as collider bias. The present author argues that the obesity paradox reflects the latter—a product of a statistical bias—and emphasizes that, while these findings are hypothesis generating, they will not alter clinical practice or recommendations.
Literatur
1.
Zurück zum Zitat World Cancer Research Fund (WCRF) (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective, 2nd edn. American Institute for Cancer Research, Washington World Cancer Research Fund (WCRF) (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective, 2nd edn. American Institute for Cancer Research, Washington
2.
Zurück zum Zitat Renehan A, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578PubMedCrossRef Renehan A, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578PubMedCrossRef
3.
Zurück zum Zitat Doyle C, Kushi LH, Byers T et al (2006) Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 56:323–353PubMedCrossRef Doyle C, Kushi LH, Byers T et al (2006) Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 56:323–353PubMedCrossRef
4.
Zurück zum Zitat Parkin E, O’Reilly DA, Sherlock DJ, Manoharan P, Renehan AG (2014) Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obes Rev 15:434–451PubMedCrossRef Parkin E, O’Reilly DA, Sherlock DJ, Manoharan P, Renehan AG (2014) Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obes Rev 15:434–451PubMedCrossRef
5.
Zurück zum Zitat Schlesinger S, Siegert S, Koch M et al. (2014) Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis. Cancer Causes Control. doi:10.1007/s10552-014-0435-x Schlesinger S, Siegert S, Koch M et al. (2014) Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis. Cancer Causes Control. doi:10.​1007/​s10552-014-0435-x
6.
Zurück zum Zitat Carnethon MR, De Chavez PJ, Biggs ML et al (2012) Association of weight status with mortality in adults with incident diabetes. JAMA 308:581–590PubMedCentralPubMed Carnethon MR, De Chavez PJ, Biggs ML et al (2012) Association of weight status with mortality in adults with incident diabetes. JAMA 308:581–590PubMedCentralPubMed
7.
Zurück zum Zitat Logue J, Walker JJ, Leese G et al (2013) Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 36:887–893PubMedCentralPubMedCrossRef Logue J, Walker JJ, Leese G et al (2013) Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 36:887–893PubMedCentralPubMedCrossRef
8.
9.
Zurück zum Zitat Lavie CJ, Milani RV, Ventura HO (2009) Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53:1925–1932PubMedCrossRef Lavie CJ, Milani RV, Ventura HO (2009) Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53:1925–1932PubMedCrossRef
10.
Zurück zum Zitat Romero-Corral A, Montori VM, Somers VK et al (2006) Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368:666–678PubMedCrossRef Romero-Corral A, Montori VM, Somers VK et al (2006) Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368:666–678PubMedCrossRef
11.
Zurück zum Zitat Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA (2008) Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156:13–22PubMedCrossRef Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA (2008) Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156:13–22PubMedCrossRef
12.
Zurück zum Zitat Carman WJ, Barrett-Connor E, Sowers M, Khaw KT (1994) Higher risk of cardiovascular mortality among lean hypertensive individuals in Tecumseh, Michigan. Circulation 89:703–711PubMedCrossRef Carman WJ, Barrett-Connor E, Sowers M, Khaw KT (1994) Higher risk of cardiovascular mortality among lean hypertensive individuals in Tecumseh, Michigan. Circulation 89:703–711PubMedCrossRef
13.
Zurück zum Zitat Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP (1999) Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160:1856–1861PubMedCrossRef Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP (1999) Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160:1856–1861PubMedCrossRef
14.
Zurück zum Zitat Yoon HH, Lewis MA, Shi Q et al (2011) Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol 29:4561–4567PubMedCentralPubMedCrossRef Yoon HH, Lewis MA, Shi Q et al (2011) Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol 29:4561–4567PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Hakimi AA, Furberg H, Zabor EC et al (2013) An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst 105:1862–1870PubMedCentralPubMedCrossRef Hakimi AA, Furberg H, Zabor EC et al (2013) An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst 105:1862–1870PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML (2006) Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology. 68:741–746PubMedCrossRef Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML (2006) Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology. 68:741–746PubMedCrossRef
17.
Zurück zum Zitat Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG (2010) Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 19:3119–3130CrossRef Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG (2010) Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 19:3119–3130CrossRef
18.
Zurück zum Zitat Crosbie EJ, Roberts C, Qian W, Swart AM, Kitchener HC, Renehan AG (2012) Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. Eur J Cancer 48:853–864PubMedCrossRef Crosbie EJ, Roberts C, Qian W, Swart AM, Kitchener HC, Renehan AG (2012) Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. Eur J Cancer 48:853–864PubMedCrossRef
19.
Zurück zum Zitat Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 103:250–263PubMedCentralPubMedCrossRef Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 103:250–263PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Speakman JR (2014) If body fatness is under physiological regulation, then how come we have an obesity epidemic? Physiol (Bethesda) 29:88–98 Speakman JR (2014) If body fatness is under physiological regulation, then how come we have an obesity epidemic? Physiol (Bethesda) 29:88–98
21.
Zurück zum Zitat Rothman KJ (2008) BMI-related errors in the measurement of obesity. Int J Obes (Lond) 32(Suppl 3):S56–S59CrossRef Rothman KJ (2008) BMI-related errors in the measurement of obesity. Int J Obes (Lond) 32(Suppl 3):S56–S59CrossRef
22.
Zurück zum Zitat Vina J, Borras C, Gomez-Cabrera MC (2013) Overweight, obesity, and all-cause mortality. JAMA 309:1679PubMedCrossRef Vina J, Borras C, Gomez-Cabrera MC (2013) Overweight, obesity, and all-cause mortality. JAMA 309:1679PubMedCrossRef
23.
Zurück zum Zitat Durazo-Arvizu RA, Cooper RS (2008) Issues related to modeling the body mass index-mortality association: the shape of the association and the effects of smoking status. Int J Obes (Lond) 32(Suppl 3):S52–S55CrossRef Durazo-Arvizu RA, Cooper RS (2008) Issues related to modeling the body mass index-mortality association: the shape of the association and the effects of smoking status. Int J Obes (Lond) 32(Suppl 3):S52–S55CrossRef
24.
Zurück zum Zitat Strandberg TE, Stenholm S, Strandberg AY, Salomaa VV, Pitkala KH, Tilvis RS (2013) The “obesity paradox,” frailty, disability, and mortality in older men: a prospective, longitudinal cohort study. Am J Epidemiol 178:1452–1460PubMedCrossRef Strandberg TE, Stenholm S, Strandberg AY, Salomaa VV, Pitkala KH, Tilvis RS (2013) The “obesity paradox,” frailty, disability, and mortality in older men: a prospective, longitudinal cohort study. Am J Epidemiol 178:1452–1460PubMedCrossRef
25.
Zurück zum Zitat Flegal KM, Graubard BI, Williamson DF, Cooper RS (2011) Reverse causation and illness-related weight loss in observational studies of body weight and mortality. Am J Epidemiol 173:1–9PubMedCrossRef Flegal KM, Graubard BI, Williamson DF, Cooper RS (2011) Reverse causation and illness-related weight loss in observational studies of body weight and mortality. Am J Epidemiol 173:1–9PubMedCrossRef
26.
Zurück zum Zitat Lawlor DA, Hart CL, Hole DJ, Davey SG (2006) Reverse causality and confounding and the associations of overweight and obesity with mortality. Obes (Silver Spring) 14:2294–2304CrossRef Lawlor DA, Hart CL, Hole DJ, Davey SG (2006) Reverse causality and confounding and the associations of overweight and obesity with mortality. Obes (Silver Spring) 14:2294–2304CrossRef
27.
Zurück zum Zitat Renehan AG, Crosbie EJ, Campbell PT (2014) Re: prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst 106:djt375PubMedCrossRef Renehan AG, Crosbie EJ, Campbell PT (2014) Re: prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst 106:djt375PubMedCrossRef
28.
Zurück zum Zitat Hernan MA, Hernandez-Diaz S, Robins JM (2004) A structural approach to selection bias. Epidemiology 15:615–625PubMedCrossRef Hernan MA, Hernandez-Diaz S, Robins JM (2004) A structural approach to selection bias. Epidemiology 15:615–625PubMedCrossRef
30.
Zurück zum Zitat Hernandez-Diaz S, Schisterman EF, Hernan MA (2006) The birth weight “paradox” uncovered? Am J Epidemiol 164:1115–1120PubMedCrossRef Hernandez-Diaz S, Schisterman EF, Hernan MA (2006) The birth weight “paradox” uncovered? Am J Epidemiol 164:1115–1120PubMedCrossRef
Metadaten
Titel
RETRACTED ARTICLE: The ‘obesity paradox’ and survival after colorectal cancer: true or false?
verfasst von
Andrew G. Renehan
Publikationsdatum
01.10.2014
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 10/2014
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0436-9

Weitere Artikel der Ausgabe 10/2014

Cancer Causes & Control 10/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.